The first model, called E-morph assay, is based on ER-alpha expressing MCF7 breast cancer cells and evaluates the changes in adhesion junction (AJ) organization as an indicator for anti-estrogenic or estrogenic effects (Kornhuber et al., 2021). The gene discussed is ESR1; the disease is breast carcinoma.